Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | 0.000% | -5.941% | -2.062% | 88.119% | 14.458% | -4.040% | -60.417% |
| Northwest Biotherapeutics Inc. | 0.000% | -8.889% | -0.606% | -36.923% | -20.388% | -63.717% | -85.091% |
| Celldex Therapeutics | -1.670% | -0.071% | 3.285% | 67.456% | 28.636% | -14.242% | 28.871% |
News
1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $10,000 and Hold for the Long Term
The artificial intelligence (AI) infrastructure market is booming. The five largest spenders on data center infrastructure are forecast to invest more than $700 billion this year. That is more than
Prediction: This Artificial Intelligence (AI) Growth Stock Will Be the Nasdaq's Best Performer by Year-End
Technology stocks have made a roaring comeback after getting battered in the first quarter of 2026, as evidenced by the recent surge in the Nasdaq Composite index.
The index has shot up 13.7% so far
Fund Cuts $2.8 Million ESG ETF Stake Even as Shares Jump 42% in a Year
On April 22, 2026, Invera Wealth Advisors disclosed in an SEC filing that it sold 47,883 shares of the iShares ESG Advanced MSCI USA ETF (NASDAQ:USXF) in the first quarter, an estimated $2.77